Literature DB >> 15176947

Vaccines against Francisella tularensis--past, present and future.

J Wayne Conlan1.   

Abstract

Francisella tularensis is a facultative intracellular bacterial pathogen capable of causing a spectrum of human diseases collectively called tularemia. The pathogen is highly infectious and some strains can cause rapidly lethal infection especially when inhaled. The latter were developed as biological weapons in the past and nowadays cause concern as potential bioterrorism agents. A live attenuated strain of the pathogen was developed more that 40 years ago and remains the sole prophylactic measure against the pathogen. Research to develop better live and subunit vaccines is under way. The former will require an understanding of the virulence factors of F. tularensis and a facile means of mutating them and the latter will require identification of the protective antigens of the pathogen. The current vaccine and its potential replacements are the focus of this review.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15176947     DOI: 10.1586/14760584.3.3.307

Source DB:  PubMed          Journal:  Expert Rev Vaccines        ISSN: 1476-0584            Impact factor:   5.217


  28 in total

1.  A mutant of Francisella tularensis strain SCHU S4 lacking the ability to express a 58-kilodalton protein is attenuated for virulence and is an effective live vaccine.

Authors:  Susan Twine; Mona Byström; Wangxue Chen; Mats Forsman; Igor Golovliov; Anders Johansson; John Kelly; Helena Lindgren; Kerstin Svensson; Carl Zingmark; Wayne Conlan; Anders Sjöstedt
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

2.  Resistance of Francisella tularensis strains against reactive nitrogen and oxygen species with special reference to the role of KatG.

Authors:  Helena Lindgren; Hua Shen; Carl Zingmark; Igor Golovliov; Wayne Conlan; Anders Sjöstedt
Journal:  Infect Immun       Date:  2007-01-08       Impact factor: 3.441

3.  IL-10 restrains IL-17 to limit lung pathology characteristics following pulmonary infection with Francisella tularensis live vaccine strain.

Authors:  Samantha R Slight; Leticia Monin; Radha Gopal; Lyndsay Avery; Marci Davis; Hillary Cleveland; Tim D Oury; Javier Rangel-Moreno; Shabaana A Khader
Journal:  Am J Pathol       Date:  2013-09-03       Impact factor: 4.307

4.  Interleukin-6 is essential for primary resistance to Francisella tularensis live vaccine strain infection.

Authors:  Sherry L Kurtz; Oded Foreman; Catharine M Bosio; Miriam R Anver; Karen L Elkins
Journal:  Infect Immun       Date:  2012-12-10       Impact factor: 3.441

Review 5.  Technical transformation of biodefense vaccines.

Authors:  Shan Lu; Shixia Wang
Journal:  Vaccine       Date:  2009-11-05       Impact factor: 3.641

6.  Immunoproteomics analysis of the murine antibody response to vaccination with an improved Francisella tularensis live vaccine strain (LVS).

Authors:  Susan M Twine; Mireille D Petit; Kelly M Fulton; Robert V House; J Wayne Conlan
Journal:  PLoS One       Date:  2010-04-02       Impact factor: 3.240

7.  Mucosal immunotherapy for protection from pneumonic infection with Francisella tularensis.

Authors:  Ryan M Troyer; Katie L Propst; Jeff Fairman; Catherine M Bosio; Steven W Dow
Journal:  Vaccine       Date:  2009-05-31       Impact factor: 3.641

8.  An improved vaccine for prevention of respiratory tularemia caused by Francisella tularensis SchuS4 strain.

Authors:  Chandra Shekhar Bakshi; Meenakshi Malik; Manish Mahawar; Girish S Kirimanjeswara; Karsten R O Hazlett; Lance E Palmer; Martha B Furie; Rajendra Singh; J Andres Melendez; Timothy J Sellati; Dennis W Metzger
Journal:  Vaccine       Date:  2008-08-08       Impact factor: 3.641

9.  Diverse myeloid and lymphoid cell subpopulations produce gamma interferon during early innate immune responses to Francisella tularensis live vaccine strain.

Authors:  Roberto De Pascalis; Betsy C Taylor; Karen L Elkins
Journal:  Infect Immun       Date:  2008-06-23       Impact factor: 3.441

10.  MglA and Igl proteins contribute to the modulation of Francisella tularensis live vaccine strain-containing phagosomes in murine macrophages.

Authors:  Linda Bönquist; Helena Lindgren; Igor Golovliov; Tina Guina; Anders Sjöstedt
Journal:  Infect Immun       Date:  2008-05-12       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.